卡迪奥肺部炼测试 transthyretin amyloid心肌病患者:一个长期后续研究研究
Robin Willixhofer1, René Rettl1, Christina Kronberger1
1Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna.
Journal of cardiovascular medicine (Hagerstown, Md.)
|July 16, 2024
概括
晶氨基氨基酸心肌病患者的功能能力最初有所改善,但后来下降. 氧气消耗高于14毫升/千克/分钟,通风到二氧化碳倾斜率低于40表示预后更好.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 晶氨基氨基酸心肌病变 (ATTR-CM) 显著损害患者的功能能力.
- 评估随着时间的推移功能能力的变化对于管理ATTR-CM至关重要.
研究的目的:
- 用心肺运动测试 (CPX) 来评估ATTR-CM患者功能能力的纵向变化.
- 为了确定ATTR-CM进展的预后标志物.
主要方法:
- 34名ATTR-CM患者在基线,8个月 (V1) 和35个月 (V2) 接受了系列CPX和血液测试.
- 分析的CPX关键参数包括峰值工作能力,峰值氧气消耗 (VO2) 和通风到二氧化碳倾斜率 (VE/VCO2).
主要成果:
- 功能能力,以峰值工作能力和峰值VO2表示,在V1有所改善,但在V2下降.
- 在V2时,VE/VCO2斜率显著增加,表明心肺功能恶化.
- 峰值VO2<14毫升/千克·分钟和VE/VCO2斜率>40与增加的死亡率和心力衰竭住院病例有关.
结论:
- 在ATTR-CM患者中,短期的功能能力有所改善,其后长期的功能能力恶化.
- 峰值VO2>14毫升/千克·分钟和VE/VCO2斜率<40是ATTR-CM中有利的预后指标.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...


